Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Capsaicin Desensitization and UVB Inflammation
NCT03587220Completed
- Sponsor
- Aalborg University
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Trial of capsaicin 8% patch in neuropathic pain, sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion at 7 days and Warm Detection Thresholds at 7 days. Started Aug 2018; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03587220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587220.